31 citations · 32 across the 3 of their papers we have counts for
3 papers
Should the pharmaceutical industry consider using high-order autoregressive models when modelling panel data?
Dan Jackson, Fanni Zhang, Abdul-Azeez Ganiyu +1
Longitudinal data, often in the form of panel data, are commonly encountered in the pharmaceutical industry. However it is not always possible to fit an unstructured covariance mat…
Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs
Michael Sweeting, Daniel Slade, Dan Jackson +1
Dose-finding trials are a key component of the drug development process and rely on a statistical design to help inform dosing decisions. Triallists wishing to choose a design requ…
Bivariate network meta-analysis for surrogate endpoint evaluation
Sylwia Bujkiewicz, Dan Jackson, John R Thompson +3
Surrogate endpoints are very important in regulatory decision-making in healthcare, in particular if they can be measured early compared to the long-term final clinical outcome and…